News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Sanofi-Aventis (France) to Buy Brazil’s Medley for About $700 Million
April 6, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
PARIS, April 3 (Reuters) - France's Sanofi-Aventis (SASY.PA) plans to buy Brazilian generic drugmaker Medley next week for about $700 million, Le Figaro reported in a preview of its weekend edition without saying where it obtained the information.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Mergers & acquisitions
South America
Europe
Sanofi
MORE ON THIS TOPIC
Funding
Degron adds $40M to series A, supporting immunology plans for molecular glue platform
May 14, 2026
·
2 min read
·
Tristan Manalac
Layoffs
Takeda’s ‘transformation program’ leaves 4,500 jobless
May 14, 2026
·
2 min read
·
Tristan Manalac
Job Trends
Hiring outlook: job opportunities on
BioSpace
rise YOY, but layoffs affect thousands
May 14, 2026
·
3 min read
·
Angela Gabriel
Earnings
Goodbye Galapagos: chameleon company exits the island, rebrands as Lakefront
May 13, 2026
·
2 min read
·
Heather McKenzie
